Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis
- DOI
- 10.5217/ir.2026.00100
- Published
- 2026-07-27
- Container
- Intestinal Research
- Publisher
- Korean Association for the Study of Intestinal Diseases
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.5217/ir.2026.00100,
title = {Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis},
author = {Akhil Deepak Vatvani and Timotius Ivan Hariyanto and Daniel Gonzalez Mosquera and Stephanie Stephanie},
year = {2026},
journal = {Intestinal Research},
doi = {10.5217/ir.2026.00100},
url = {https://doi.org/10.5217/ir.2026.00100}
}RIS
TY - JOUR TI - Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis AU - Akhil Deepak Vatvani AU - Timotius Ivan Hariyanto AU - Daniel Gonzalez Mosquera AU - Stephanie Stephanie PY - 2026 JO - Intestinal Research DO - 10.5217/ir.2026.00100 UR - https://doi.org/10.5217/ir.2026.00100 ER -
APA
Vatvani, A. D., Hariyanto, T. I., Mosquera, D. G., & Stephanie, S. (2026). Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis. Intestinal Research. https://doi.org/10.5217/ir.2026.00100
Source records
- crossref · retrieved 2026-09-25T00:36:44.110Z